Development of an arthroscopically compatible polymer additive layer manufacture technique by Partridge SW et al.
Development of an Arthroscopically Compatible 
Polymer Additive Layer Manufacture Technique 
Simon W Partridge1,*, Matthew J Benning1, Matthew J German² and Kenneth W 
Dalgarno1. 
1 School of Mechanical and Systems Engineering, Newcastle University, Newcastle upon-
Tyne, UK. 
² Centre for Oral Health Research, School of Dental Sciences, Newcastle University, 
Newcastle upon Tyne, UK. 
*Corresponding author: simon.partridge@ncl.ac.uk. 
 
1 Abstract 
This paper describes a proof of concept study designed to evaluate the potential for an 
in-vivo 3D printing route to support minimally invasive repair of the musculoskeletal 
system.  The study uses a photocurable material to additively manufacture in-situ a 
model implant, and demonstrates that this can be achieved effectively within a clinically 
relevant timescale.  The approach has the potential to be applied with a wide range of 
light curable materials, and with development could be applied to create functionally 
gradient structures in-vivo. 
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2 Introduction 
The use of minimally invasive techniques for surgical interventions offers clear 
advantages to both the healthcare system and to the patient.1 Procedures are generally 
quicker, the degree of surgical insult is lower, which means that hospital stays and 
rehabilitation periods are shorter, which in turn offers a faster return to work and 
society for the patient. For the musculoskeletal system arthroscopic techniques are 
commonly used to enable examination, biopsy, debridement, and microfracture.  In 
order to seek to repair the musculoskeletal system with minimal invasion, materials 
which can be injected into the body have been developed, notably cements for 
vertebroplasty and kyphoplasty procedures2, and polymeric or particulate bone defect 
filling materials.  More recently there has been interest in the arthroscopic delivery of 
osteochondral plugs to treat small joint defects3,4, but this approach has not yet 
progressed to clinical adoption. 
An alternative approach to bulk injection of a material is to use additive manufacturing 
to build up a 3D structure through the sequential formation and bonding of layers of 
material together.  Previous work has shown that additive manufacture can, in principle, 
be used to fill joint defects5, but has not yet been explored how this could be achieved 
minimally invasively.  This approach offers potential advantages over existing injectable 
approaches as it could extend the range of materials which could be processed using a 
minimally invasive approach, by allowing the use of materials which cure or set more 
effectively in small volumes.  In addition, the approach could be used to develop multi-
material structures in order to provide a functionally gradient implant. 
A potential methodology for clinical application is outlined schematically in figure 1.  
Preparation of the implant site would involve removing damaged tissue and providing a 
lining to the defect to temporarily isolate the site whilst development of the implant 
took place.  Sequential deposition and in-situ curing, in this case through blue light, of 
material would then be used to develop the implant through additive manufacture in-
vivo.  Visible light is non-thermogenic, less damaging to the cells and provides curing at 
higher depths in comparison to UV light6,7.  Blue light curing is an attractive approach as 
it has been clinically applied widely in dentistry and with a higher depth penetration in 
comparison to violet light7–9. 
 
Figure 1 – Arthroscopic In-vivo Manufacture.  Envisaged process is (a) preparation 
and isolation of the defect site; (b) deposition and (c) in-situ curing of material, 
repeated to fill defect (d).   
The work presented in this paper describes a proof of concept study undertaken to 
understand if a blue light curable material could be effectively delivered arthroscopically 
in order to fill a model osteochondral defect within a clinically useful timescale.  HEMA 
(hydroxyethylmethacrylate) monomer was chosen as a model material for the study: it 
is a dental filler material with established blue light cure protocols, and well understood 
cure characteristics. 
3 Materials and Methods 
3.1 Materials and Preparation 
Table 1 details the reagents used to create the HEMA solutions, and table 2 shows the 
constitution of the three solutions and the role of the different materials in the blue light 
cure system.  Langer et al. (1999)10 used a 1% w/v. % in a 1:1 ratio of camphorquinone 
(CQ) to amine, however others such as Dewaele et al. (2009)11 have used a 0.5 w/v. % 
1:1 ratio.  To determine whether the concentration of components in these systems 
work with the mono methyl ether hydroquinone (MEHQ) inhibited HEMA monomer the 
w/v. % and ratio were investigated at these reported values.  The solutions were 
prepared by weighing CQ and ethyl 4-(dimethylamino) benzoate (EDMAB) into an amber 
glass vial with black polytetrafluoroethylene (PTFE) faced rubber lined cap (fisher 
Scientific, 11309493).  Using a pipette triethylene glycol dimethacrylate (TEGDMA) was 
then added until it constituted 0.5 mol% of HEMA into the solution.  The solution was 
then mixed for 1 hour using an SRT6 Stuart® tube roller (Bibby Scientific Ltd., 
Staffordshire, UK).  
Chemical Acronym MEHQ mol% 
Product 
number 
Role 
2-Hydroxyethylmethactylate HEMA ≤250 97 128635 Monomer 
Camphorquinone CQ 0 - 21325 Photoinitiator 
Ethyl 4-(dimethylamino) 
benzoate 
EDMAB 0 - E24905 Activator 
Triethylene glycol 
dimethacrylate 
TEGDMA 
80 – 
120 
95 261548 Cross-linker 
Table 1: Chemicals used for the formulation of photocurable HEMA solutions.  All 
reagents purchased from Sigma Aldrich (Poole, UK). 
 
 HEMA Mol % 
TEGDMA  
mol/HEMA mol% 
Camphorquinone  
(w/v. %) 
EDMAB  
(w/v. %) 
A 96.5 0.5 1 1 
B 96.5 0.5 1 0.5 
C 96.5 0.5 0.5 1 
Table 2: Photocurable HEMA solutions compositions. 
 
3.2 Materials Processing 
3.2.1 Light Source 
A Cree® XLamp® XP-E LED (royal blue) 450-465 nm (Cree Inc., North Carolina, USA) was 
used with an optical PMMA LED lens (LEDiL, FP11085, Salo, Finland).  Power was 
supplied by a British Standards Tester PSM 3/2A 3 channel regulated DC power supply 
(BSIgroup, London, UK).  The radius of the illumination spot was measured as 0.5 cm 
when it was 1 cm from the lens, and the LED was operated at 734 mA, which gave an 
estimated power output of 1000 mW/cm2. 
3.2.2 Mould and Photocuring Chamber 
A two-part PTFE mould was fabricated to provide an array of model defects.  The top 
part of the PTFE mould consisted of an array of nine holes 8 mm in diameter with a 2 
mm deep couterbore of 40 mm diameter cut to act as a location feature for the 
photocuring chamber.  The base part of the PFTE mould consisted of an array of pins 8 
mm in diameter aligned to fit into the holes in the top part.  Upon assembly, the wells 
were 8 mm in diameter with 6 mm depth (figure 1), chosen to be representative of small 
osteochondral defects. 
     
Figure 1: Schematic diagram of the PTFE mould assembly (left) and image of the 
assembled PTFE mould (right). 
The photocuring chamber consisted of a closed 3D printed PLA cylinder of 40 mm 
diameter with a central 3 mm hole for connecting the LED holder and a 5 mm hole for 
the wires and nitrogen inlet (figure 2).  The PMMA LED lens was mounted to the XP-LED 
and attached to an aluminium column with Artic Silver®5 thermal paste (Visalia, CA, 
USA). 
                
Figure 2: A) Schematic of the photocuring chamber and PTFE mould cross-section.  
B) Image example, full assembly of the photocuring chamber (without nitrogen 
tube) positioned on the PTFE mould. 
3.2.3 HEMA Polymerisation 
The photochemical process of polymerisation depends on the transfer of reactive 
species generated by the photoinitiator CQ in response to blue light.  The transfer of this 
reactive species from the CQ to the HEMA monomer is facilitated by the tertiary amide 
EDMAB and leads to propagation of the polymer chain.  The presence of oxygen within 
this system absorbs the reactive species and thus retards initiation and propagation of 
the reaction 12.  In these experiments nitrogen gas was used to displace oxygen from the 
curing chamber to diminish oxygen inhibition of the photocuring process. 
The intrinsic and extrinsic factors affecting curing efficiency are explained in detail in 
Leprince et al. (2013)12.  In terms of the exposure time the key factors include the 
formulation, volume, temperature and irradiance intensity.  Ambient temperature was 
controlled by an air conditioning unit at 20oC.   
A B 
In previous studies of blue light cure a range of blue light intensities have been used, 
ranging from 1 – 3000 mW/cm2 13,12.  The materials used in this study include the MEHQ 
inhibitor, which is added to dental formulations to provide shelf life.  In order to ensure 
that the processing conditions would mitigate MEHQ inhibition, a relatively high light 
intensity of 1000mW/cm2 was used. 
The 10 mm distance of the LED to the maximal curing base was selected as this 
illuminated the build area effectively.  From initial experiments, ~1 mm HEMA layers 
cured into a malleable disc with 1 minute exposure time, ergo controlled prolonged 
exposure time points were investigated. 
To produce ~1 mm thick layers 50 μL of the HEMA solution was pipetted into a PTFE 
mould.  The photocuring chamber with flowing nitrogen was then placed over the well 
as shown in figure 2 and the power supply activated to deliver 734 mA equating to 1000 
mW/ cm2 at the spot 10 mm from the lens.  Therefore, HEMA exposure times were 
investigated between 1 and 10 minutes. 
For multi-layered experiments this process was repeated, with no delay between the 
end of an exposure and the deposition of the material for the next layer, using 
formulation A, 734 mA, and an exposure time of 1 minute.   
3.3 Material Characterisation 
3.3.1 Fourier Transformed Infrared Spectroscopy (FTIR) 
Solid material samples were analysed using an ATR-FTIR Perkin Elmer Spectrum 100 with 
PerkinElmer’s Spectrum™ v6 FT-IR software.  Spectra were collected by cleaning the 
diamond/ZnSe crystal surface with acetone or 100% ethanol before and after use.  The 
machine was calibrated to background atmosphere prior to data collection.  The base of 
the polymerised HEMA (polyHEMA) samples were then loaded onto the diamond/ZnSe 
ATR crystal detection area and locked in place using the pressure arm.  All samples were 
polished using graded abrasive paper to ensure sufficient contact with the ATR crystal.  
Spectra were then recorded from 4000 cm-1 to 650 cm-1 with a resolution of 4 cm-1 and 
a minimum of 32 scans per sample. 
The multi-layered samples were bisected using a circular diamond blade.  The samples 
were also polished to ensure contact with the ATR crystal.  Measurements were taken 
centrally at the top and bottom of the samples (figure 3), with the ATR crystal adjacent 
to the top and bottom surfaces, and centrally in the middle of the samples halfway 
between the top and bottom measurements. 
 
Figure 3: Positioning of the ATR-FTIR detection crystal (red) on cross-sectioned 
polyHEMA cylinders (blue) 
The degree of conversion (DC) was calculated by comparing the vibrational band of the 
residual non-polymerised methacrylate C=C stretching mode at 1638 cm-1 to the 
aromatic C-C stretching mode at 1710 cm-1 used as an internal standard.  The non-
polymerised HEMA solution was used as a reference. 
3.3.2 Imaging 
The sectioned polyHEMA cylinders were imaged using a Leica M165FC with integrated 
LED spotlights.  Images were acquired and processed using DFC310 FX camera Leica with 
the Application Suite (LAS) software (Leica Microsystems Heidelberg GMBH Germany). 
Superficial heating of the sectioned polyHEMA cylinders was applied using 100oC hot air 
supplied by a TENMA 21-10125 rework station (Tokyo, Japan).  The hot air gun was 
positioned approximately 1 cm from the sample surface and held for 10-20 seconds. 
3.3.3 Dimensional Measurements 
The samples were measured using Mitutoyo digimatic calipers 0-150 mm (Mitutoyo, 
Sakado, Japan).   
3.3.4 Compression Test 
Six layer polyHEMA cylinders were tested in compression using a H25KS Tinius Olsen Ltd.  
(Surrey, UK) testing machine with a 25 kN load cell.  The cylinders were initially trimmed 
at each end to create parallel surfaces.  The crosshead speed was 2 mm/ minute and 
samples were tested to failure. 
3.4 Statistical Methods 
Collected data were processed and formatted using Microsoft Excel 2016.  Statistical 
data analysis was performed using GraphPad Prism 6®.  One-way analysis of variance 
(ANOVA) were performed using a Tukey’s HSD post-hoc test, two-way ANOVAs were 
performed when possible to determine variation between data sets. 
4 Results 
4.1 Curing of Single Layers 
4.1.1 Morphology 
Figure 4 shows the polyHEMA discs from formulations A – C with 1 and 4 minutes 
exposure times.  After 1 minute exposure the polyHEMA discs from formulations A and 
C have strong yellow colour.  The discs all had a meniscus, with some material failing to 
cover the PTFE mould surface (denoted by the arrows in figure 4A).  Figure 4B shows 
that apart from those samples where material coverage was incomplete the diameter 
of the samples was consistent and not significantly affected by exposure time. 
4.2  FTIR and Degree of Conversion 
Figure 5A shows the ATR-FTIR spectra from single layer specimens of formulation A 
following exposure for 1-10 minutes, indicating that 1 minute of exposure was sufficient 
for the radical polymerisation reaction to take place.  Results from figure 5B indicate no 
significant differences between the degree of conversion of HEMA monomer from the 
different formulations across all of the exposure times.  
  
 
 
 
Figure 4: A) images of polyHEMA discs from formulations A-C following 
photopolymerisation with 1 and 4 minutes exposure (10 mm scale bar).  Arrows 
denote incomplete coverage of mould surface B) Diameter of polyHEMA discs.  
Bars shows the mean ± the standard deviation. 
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Figure 5: A) ATR-FTIR spectra of formulation A before and after 1 minute 
exposure.  Narrow scan from 1550 – 1800 cm-1 showing aliphatic C-C (1710 cm-1) 
and aromatic C=C (1638 cm-1) vibrational modes.  B) The degree of HEMA 
monomer conversion from formulations A-C.  The bars represent the mean ± the 
standard deviation (n = 3). 
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4.3 Multiple layer curing 
4.4 Morphology 
Figure 6A shows that the multi-layer polyHEMA cylinders retained the meniscus 
throughout the addition of further layers.  Superficial heating of the cut surface of the 
polyHEMA plugs revealed curved lined features correlating to the layer interfaces (figure 
6B). 
Figure 6C shows that the cylinders were broadly consistent in diameter, although the 
single layer specimens were on average around 2% smaller in diameter than the multi-
layer specimens.  The sequential weight gains were broadly as would be expected, as 
were most of the height gains, apart from layers 4 and 5 where some levelling out of the 
meniscus seems to occur.  Note that the height of layer 1 is misleading: in all cases the 
height measurement was to the top of the meniscus. 
4.5 Degree of Conversion 
Figure 7 (left) shows ATR-FTIR analysis of the base layer degree of conversion following 
sequential layer addition, and indicates no significant difference in degree of conversion 
of the polymer on the base layer for samples of different heights.  In addition, ATR-FTIR 
of the cross-sectioned samples, figure 7 (right), shows that the degree of conversion 
through the layers remained consistent throughout, with no significant differences in 
DC. 
4.6 Mechanical Properties 
Compression testing with 6-layer samples gave an average modulus of 204 MPa (min 
184 MPa, max 240 MPa), and an average compressive strength of 82 MPa (min 69 MPa, 
max 92 MPa).  
  
 
Figure 6: A) Images of polyHEMA cylinders with 1 – 6 layers (10 mm scale bar).  B) 
Stereomicroscope images of sectioned 6-layer polyHEMA cylinders following 
superficial heat treatment.  C) Average diameter, edge height and weight of 
polyHEMA cylinders per layer.  Dashed grid represents expected values per layer.  
Bars shows the mean ± the standard deviation (n = 3).  
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 Figure 7: Base layer DC following sequential layer-by-layer exposure (left) and 
cross-sectional DC within the polyHEMA cylinders (right).  Bars show the mean ± 
the standard deviation (n = 3). 
5 Discussion 
5.1 Effectiveness of the Processing Route in Curing HEMA 
The curing of single layers resulted in some incomplete surface coverage, which 
remained inconsistent.  This was most likely caused by poor wettability of the HEMA 
mixture on the PTFE substrate.  However, the single layer experiments were valuable in 
showing that the 1 minute exposure time was sufficient to stimulate polymerisation of 
composition A.  The sequential layer photopolymerisation processing route produced 
solid, robust polyHEMA cylinders which filled the model defects, with 6-layer cylinders 
produced in less than 10 minutes.  The average degree of conversion for the multi-layer 
specimens was between 50% and 60%.  The degree of conversion achieved was typical 
of blue light cured methacrylate based dental filler materials (for example Galvao et al. 
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(2013)14 quote 55% for PMMA processed using conventional dental curing equipment; 
and Marovic et al. (2013)15 quote around 60% for a range of methacrylate based 
materials), so the processing route is considered to have achieved a DC broadly 
equivalent to that achieved in commercial light cured materials.  We consider that a 
useful volume of material could be delivered and polymerised in-situ at a rate which is 
clinically practical, and so the approach is considered to have clinical promise. 
5.2 Potential for Clinical Application  
HEMA was used within this study as a model material with which to perform the proof 
of concept study – it does not have the biological properties for clinical application in a 
musculoskeletal application.  In order for the approach to be viable for an orthopaedic 
application, the process would require the use of materials which would have in-vivo 
properties relevant to the musculoskeletal system.  However, there is a significant body 
of work on photocurable materials which could have clinical application.  Table 3 
summarises materials which have potential to be applied to the musculoskeletal system 
using the arthroscopic approach outlined in this paper, and includes modified HEMA 
systems which could have potential alongside a range of other materials.  For the most 
part these materials are not yet commercially available, but there is clear potential for 
an approach like the one outlined in this paper to be adopted for their use.  Indeed 
several photocurable monomer systems have been used in additive manufacturing of 
cell – hydrogel constructs outlined in an excellent review by Melchels et al (2012)16.  
Whilst the light curing kinetics will vary from material system to material system the rate 
at which the model plugs could be made within the proof of concept study gives 
confidence that delivery and cure in-situ of a wider range of materials within clinically 
relevant timescales will be possible.  There is also the potential to reinforce the polymers 
with a nano-scale bioceramic, and with an appropriate material delivery system 
functionally gradient composites could be created.  The overall material system could 
be inert and biocompatible, designed to stay as deposited, or bioactive, designed to 
resorb over time and be replaced with natural tissue, and table 3 identifies both inert 
and bioactive materials. 
Category Material/Reference Targeted tissue Comments 
Synthetic 
polymers 
Polyurethanes17 
Soft tissue 
 
Polyurethane incorporating hydrolysable soft segments such as PCL or polypropylene glycol: 
In-vivo tested – 6 mm x 2 mm cylindrical discs subcutaneous implantation Wistar rats. 
In-vivo tested – 1 mL injected intramuscular injection dorsum Wistar rats. 
Polylactic acid (PLA) 18,18 
Hard/ soft tissue 
Bone and heart 
Ethylene glycol – lactic acid oligomer (2EG10LA): Critical size defect model Sprague-Dawley rats 8 mm defect 
Poly(TMC-DLLA): In-vitro assessment cardiomyocytes. 
Polyhydroxyalkanoates (PHB)19 Hard/ soft tissue PHB-co-hydroxyvalerate and HEMA membranes: No in-vitro cell/ in-vivo testing 
Polyethers20 Soft tissue 
A number of polyethers such as poly(ethylene glycol) (PEG) are used to as part of oligomers and triblock copolymers. PCL-b-PEG-b-PCL: 
In-vitro assessment for adherence of fibroblasts. 
Polycaprolactone (PCL) 17,21,22 Soft tissue Poly(-caprolactone-co-trimethylene carbonate): In-vitro assessment of endothelial cells and cardiomyocytes. 
Poly(propylene fumarate) (PPF)23,24 
Hard tissue 
Bone 
PFF: 3D printed structures assessed for 112 days in-vitro with fibroblasts  
PFF/HEMA/Bioglass: 2D in-vitro assessment using human malignant melanoma cells. Bone adhesion mechanical tests. 
poly(trimethylene carbonate) 
(TMC)21,22,25 
Soft tissue 
Cartilage 
PEG-TMC and TMC-PCL-TMC: Fused filament fabricated 3D scaffolds assessed in-vitro with patient derived human mesenchymal stem cells (MSC). 
Enzymatic in-vitro degradation assay. 
Poly(TMC-DLLA): In-vitro assessment cardiomyocytes. 
Polyphosphoesters (PPE)26 
Hard/ soft tissue  
Bone 
Poly(6-aminohexyl propylene phosphate) (PPE) modified with acylated PEG (PPE-PEG):In-vitro: MSC 90%+ viability to monomer (max 10 mg/mL). MSC 
encapsulated in 8 mm diameter cylinders with 150 μL monomer solution (~3 mm height). 
Polyanhydrides10,27 
Hard/ soft tissue 
Bone 
Poly(sebacic anhydride): In-vivo tested (4 days)– material was filled into 2 mm drilled tibia defect in Sprague-Dawley rats. New collagen and blood 
vessel formation observed around the implant site. 
Hydroxyaptite nanoparticle filled polyanhydride – no in-vitro cell/ in-vivo testing. 
polyHEMA28,29 Soft tissue 
HEMA and diethylene glycol dimethacrylate: No in-vitro study. 
HEMA grafted with polyamidoamine: In-vitro assessment encapsulating human MSC in a 1 cm diameter 3 mm height. 
Triblock polymers20 Hard/ soft tissue PLA-b-PCL-b-PLA, PGA-b-PCL-b-PGA, PCL-b-PEO-b-PCL: In-vitro assessments Cell attachment study (2004). 
Natural 
polymers 
Alginate30 Soft tissue Alginate methacrylate: No in-vitro assessment. 
Hyaluronic acid30,31 Soft tissue Hyaluronan methacrylate: No in-vitro assessment. 
Gelatin32,33,34,35 Soft tissue 
Gelatin methacrylate (GelMA): 
In-vitro:5 mm diameter cylinder with 2 mm thickness) 
in-vivo: C57BL/6J mice 1 mL injected subcutaneously. 
Pullulan36 Soft tissue Pullulan methacrylate. In-vitro assessment: Encapsulation of NIH 3T3 fibroblasts, HepG2 liver cells and endothelial cells assessed for viability. 
Gellan-gum37 
Soft/ hard tissue 
Bone 
Gellan-gum methacrylate: In-vitro assessment: Adipose derived stem cells encapsulated and assessed using hydrogel on-chip process. Demonstrated 
in-vitro spontaneous differentiation into the osteogenic lineage. 
 Chitosan7 Soft tissue 
Methacrylated glycol chitosan. 
In-vitro assessment: Viability study using chondrocytes – investigated formulation cytotoxicity and influence of irradiation on encapsulated cells. 
In-vivo assessment: Osteochondral defect explant model - 4 mm diameter in New Zealand white rabbit’s knees cultured for 14 days. 
 Table 3: Summary of potential injectable photocurable biomaterials for bone and cartilage repair. 
For a range of reasons, we consider that the use of a membrane to isolate the volume 
within the body where the plug would be delivered would be required.  This would avoid 
the ingress of blood into the build volume, and would mean that monomers would not 
leach into the surrounding tissue prior to being polymerised.  As a result of the feasibility 
study a third reason can be identified: the membrane and implant materials should be 
chosen to avoid the formation of a meniscus.  Meniscus formation is controlled by the 
wettability of the wall material by the contained liquid, and so engineering the surface 
properties of the membrane offers a way of controlling the overall shape of the implant.  
The choice of membrane material would clearly also depend upon whether an inert or 
bioactive implant was being developed.  For an inert material a poly(methyl 
methacrylate) membrane would offer good levels of biocompatibility, whereas for a 
bioactive implant there are a range of possible membranes to support tissue 
regeneration38. 
6 Conclusions 
In-vivo additive manufacture using a minimally invasive approach offers an attractive 
route to the production of implants for the musculoskeletal system, and we have 
demonstrated proof of principle for a system based on light curable biomaterials.  A 
simple model system has been developed in order to build plugs of appropriate 
dimensions suitable for chemical and mechanical characterisation.  HEMA, used as a 
model material, demonstrated that appropriate volumes of material could be delivered 
within clinically relevant timescales and effectively polymerised in-situ, with minimal 
influence of the sequential layer manufacture process on the degree of conversion.  A 
wide range of light curable biomaterials, with potential for application across the 
musculoskeletal system using this processing route, are being developed. 
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